nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—Myocardial ischaemia—Ibandronate—osteoporosis	0.0195	0.0354	CcSEcCtD
Droxidopa—Blood pressure increased—Estropipate—osteoporosis	0.0164	0.0297	CcSEcCtD
Droxidopa—Blood pressure increased—Raloxifene—osteoporosis	0.0159	0.0287	CcSEcCtD
Droxidopa—Blood pressure increased—Ethinyl Estradiol—osteoporosis	0.0133	0.024	CcSEcCtD
Droxidopa—Arrhythmia—Calcium Acetate—osteoporosis	0.0129	0.0234	CcSEcCtD
Droxidopa—Syncope—Calcium Acetate—osteoporosis	0.0113	0.0205	CcSEcCtD
Droxidopa—Loss of consciousness—Calcium Acetate—osteoporosis	0.0111	0.0201	CcSEcCtD
Droxidopa—Blood pressure increased—Conjugated Estrogens—osteoporosis	0.0108	0.0196	CcSEcCtD
Droxidopa—Myocardial ischaemia—Estradiol—osteoporosis	0.0108	0.0195	CcSEcCtD
Droxidopa—Confusional state—Calcium Acetate—osteoporosis	0.0104	0.0188	CcSEcCtD
Droxidopa—Shock—Calcium Acetate—osteoporosis	0.0101	0.0183	CcSEcCtD
Droxidopa—Cardiac failure congestive—Pamidronate—osteoporosis	0.00984	0.0178	CcSEcCtD
Droxidopa—Hypertension—Ergocalciferol—osteoporosis	0.00961	0.0174	CcSEcCtD
Droxidopa—Cardiac failure congestive—Conjugated Estrogens—osteoporosis	0.00866	0.0157	CcSEcCtD
Droxidopa—Blood pressure increased—Estradiol—osteoporosis	0.00866	0.0157	CcSEcCtD
Droxidopa—Urinary tract infection—Raloxifene—osteoporosis	0.00862	0.0156	CcSEcCtD
Droxidopa—Urinary tract infection—Ibandronate—osteoporosis	0.00853	0.0155	CcSEcCtD
Droxidopa—Feeling abnormal—Calcium Acetate—osteoporosis	0.00847	0.0153	CcSEcCtD
Droxidopa—Urinary tract infection—Calcitriol—osteoporosis	0.00835	0.0151	CcSEcCtD
Droxidopa—Urinary tract infection—Ethinyl Estradiol—osteoporosis	0.00721	0.0131	CcSEcCtD
Droxidopa—Urinary tract infection—Risedronate—osteoporosis	0.00703	0.0127	CcSEcCtD
Droxidopa—Arrhythmia—Calcitriol—osteoporosis	0.00689	0.0125	CcSEcCtD
Droxidopa—Confusional state—Etidronic acid—osteoporosis	0.00681	0.0123	CcSEcCtD
Droxidopa—Dizziness—Calcium Acetate—osteoporosis	0.0068	0.0123	CcSEcCtD
Droxidopa—Urinary tract infection—Pamidronate—osteoporosis	0.00669	0.0121	CcSEcCtD
Droxidopa—Syncope—Raloxifene—osteoporosis	0.00622	0.0113	CcSEcCtD
Droxidopa—Urinary tract infection—Zoledronate—osteoporosis	0.00611	0.0111	CcSEcCtD
Droxidopa—Nausea—Calcium Acetate—osteoporosis	0.00611	0.0111	CcSEcCtD
Droxidopa—Loss of consciousness—Raloxifene—osteoporosis	0.00609	0.011	CcSEcCtD
Droxidopa—Hypertension—Ibandronate—osteoporosis	0.00592	0.0107	CcSEcCtD
Droxidopa—Arrhythmia—Risedronate—osteoporosis	0.0058	0.0105	CcSEcCtD
Droxidopa—Hypertension—Calcitriol—osteoporosis	0.0058	0.0105	CcSEcCtD
Droxidopa—Shock—Raloxifene—osteoporosis	0.00557	0.0101	CcSEcCtD
Droxidopa—Feeling abnormal—Etidronic acid—osteoporosis	0.00556	0.0101	CcSEcCtD
Droxidopa—Shock—Ibandronate—osteoporosis	0.00551	0.00998	CcSEcCtD
Droxidopa—Nausea—Ergocalciferol—osteoporosis	0.00539	0.00977	CcSEcCtD
Droxidopa—Syncope—Risedronate—osteoporosis	0.00507	0.00919	CcSEcCtD
Droxidopa—Arrhythmia—Zoledronate—osteoporosis	0.00504	0.00913	CcSEcCtD
Droxidopa—Loss of consciousness—Risedronate—osteoporosis	0.00497	0.009	CcSEcCtD
Droxidopa—Hypertension—Risedronate—osteoporosis	0.00488	0.00884	CcSEcCtD
Droxidopa—Arrhythmia—Conjugated Estrogens—osteoporosis	0.00485	0.00879	CcSEcCtD
Droxidopa—Syncope—Pamidronate—osteoporosis	0.00482	0.00873	CcSEcCtD
Droxidopa—Feeling abnormal—Alendronate—osteoporosis	0.00474	0.00859	CcSEcCtD
Droxidopa—Loss of consciousness—Pamidronate—osteoporosis	0.00472	0.00856	CcSEcCtD
Droxidopa—Urinary tract infection—Estradiol—osteoporosis	0.00471	0.00853	CcSEcCtD
Droxidopa—Hypertension—Pamidronate—osteoporosis	0.00464	0.00841	CcSEcCtD
Droxidopa—Feeling abnormal—Ibandronate—osteoporosis	0.00461	0.00836	CcSEcCtD
Droxidopa—Shock—Risedronate—osteoporosis	0.00454	0.00823	CcSEcCtD
Droxidopa—Confusional state—Pamidronate—osteoporosis	0.00442	0.00801	CcSEcCtD
Droxidopa—Syncope—Zoledronate—osteoporosis	0.0044	0.00798	CcSEcCtD
Droxidopa—Shock—Pamidronate—osteoporosis	0.00432	0.00782	CcSEcCtD
Droxidopa—Loss of consciousness—Zoledronate—osteoporosis	0.00432	0.00782	CcSEcCtD
Droxidopa—Syncope—Conjugated Estrogens—osteoporosis	0.00424	0.00768	CcSEcCtD
Droxidopa—Hypertension—Zoledronate—osteoporosis	0.00424	0.00768	CcSEcCtD
Droxidopa—Headache—Etidronic acid—osteoporosis	0.00423	0.00766	CcSEcCtD
Droxidopa—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00416	0.00753	CcSEcCtD
Droxidopa—Confusional state—Zoledronate—osteoporosis	0.00404	0.00732	CcSEcCtD
Droxidopa—Nausea—Etidronic acid—osteoporosis	0.00401	0.00726	CcSEcCtD
Droxidopa—Shock—Zoledronate—osteoporosis	0.00394	0.00714	CcSEcCtD
Droxidopa—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.0039	0.00707	CcSEcCtD
Droxidopa—Dizziness—Estropipate—osteoporosis	0.00386	0.007	CcSEcCtD
Droxidopa—Dizziness—Alendronate—osteoporosis	0.0038	0.00689	CcSEcCtD
Droxidopa—Shock—Conjugated Estrogens—osteoporosis	0.0038	0.00688	CcSEcCtD
Droxidopa—Dizziness—Raloxifene—osteoporosis	0.00374	0.00678	CcSEcCtD
Droxidopa—Dizziness—Ibandronate—osteoporosis	0.0037	0.00671	CcSEcCtD
Droxidopa—Headache—Estropipate—osteoporosis	0.00366	0.00663	CcSEcCtD
Droxidopa—Feeling abnormal—Pamidronate—osteoporosis	0.00362	0.00655	CcSEcCtD
Droxidopa—Headache—Alendronate—osteoporosis	0.0036	0.00653	CcSEcCtD
Droxidopa—Headache—Raloxifene—osteoporosis	0.00354	0.00642	CcSEcCtD
Droxidopa—Headache—Ibandronate—osteoporosis	0.00351	0.00636	CcSEcCtD
Droxidopa—Nausea—Estropipate—osteoporosis	0.00347	0.00628	CcSEcCtD
Droxidopa—Headache—Calcitriol—osteoporosis	0.00343	0.00622	CcSEcCtD
Droxidopa—Nausea—Alendronate—osteoporosis	0.00342	0.00619	CcSEcCtD
Droxidopa—Syncope—Estradiol—osteoporosis	0.00339	0.00615	CcSEcCtD
Droxidopa—Nausea—Raloxifene—osteoporosis	0.00336	0.00609	CcSEcCtD
Droxidopa—Nausea—Ibandronate—osteoporosis	0.00333	0.00603	CcSEcCtD
Droxidopa—Loss of consciousness—Estradiol—osteoporosis	0.00333	0.00602	CcSEcCtD
Droxidopa—Feeling abnormal—Zoledronate—osteoporosis	0.0033	0.00598	CcSEcCtD
Droxidopa—Hypertension—Estradiol—osteoporosis	0.00327	0.00592	CcSEcCtD
Droxidopa—Nausea—Calcitriol—osteoporosis	0.00326	0.0059	CcSEcCtD
Droxidopa—Dizziness—Ethinyl Estradiol—osteoporosis	0.00313	0.00567	CcSEcCtD
Droxidopa—Confusional state—Estradiol—osteoporosis	0.00311	0.00564	CcSEcCtD
Droxidopa—Dizziness—Risedronate—osteoporosis	0.00305	0.00553	CcSEcCtD
Droxidopa—Shock—Estradiol—osteoporosis	0.00304	0.0055	CcSEcCtD
Droxidopa—Headache—Ethinyl Estradiol—osteoporosis	0.00297	0.00537	CcSEcCtD
Droxidopa—Dizziness—Pamidronate—osteoporosis	0.0029	0.00526	CcSEcCtD
Droxidopa—Headache—Risedronate—osteoporosis	0.00289	0.00524	CcSEcCtD
Droxidopa—Nausea—Ethinyl Estradiol—osteoporosis	0.00281	0.00509	CcSEcCtD
Droxidopa—Headache—Pamidronate—osteoporosis	0.00275	0.00498	CcSEcCtD
Droxidopa—Nausea—Risedronate—osteoporosis	0.00274	0.00497	CcSEcCtD
Droxidopa—Dizziness—Zoledronate—osteoporosis	0.00265	0.0048	CcSEcCtD
Droxidopa—Nausea—Pamidronate—osteoporosis	0.00261	0.00472	CcSEcCtD
Droxidopa—Dizziness—Conjugated Estrogens—osteoporosis	0.00255	0.00462	CcSEcCtD
Droxidopa—Feeling abnormal—Estradiol—osteoporosis	0.00254	0.00461	CcSEcCtD
Droxidopa—Headache—Zoledronate—osteoporosis	0.00251	0.00455	CcSEcCtD
Droxidopa—Headache—Conjugated Estrogens—osteoporosis	0.00242	0.00438	CcSEcCtD
Droxidopa—Nausea—Zoledronate—osteoporosis	0.00238	0.00431	CcSEcCtD
Droxidopa—Nausea—Conjugated Estrogens—osteoporosis	0.00229	0.00415	CcSEcCtD
Droxidopa—Dizziness—Estradiol—osteoporosis	0.00204	0.0037	CcSEcCtD
Droxidopa—Headache—Estradiol—osteoporosis	0.00193	0.0035	CcSEcCtD
Droxidopa—Nausea—Estradiol—osteoporosis	0.00183	0.00332	CcSEcCtD
Droxidopa—ADRA1B—GPCR downstream signaling—ADCY5—osteoporosis	0.000136	0.000303	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—DKK1—osteoporosis	0.000136	0.000303	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—ENO1—osteoporosis	0.000136	0.000303	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—ADCY5—osteoporosis	0.000135	0.000302	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—ADCY5—osteoporosis	0.000135	0.000301	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NFATC1—osteoporosis	0.000135	0.000301	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—FGA—osteoporosis	0.000134	0.0003	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—ADCY5—osteoporosis	0.000134	0.0003	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PSMA2—osteoporosis	0.000134	0.000298	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PSMA5—osteoporosis	0.000134	0.000298	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—DKK1—osteoporosis	0.000134	0.000298	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—ADCY5—osteoporosis	0.000133	0.000296	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PSMA2—osteoporosis	0.000133	0.000296	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PSMA5—osteoporosis	0.000133	0.000296	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—WNT1—osteoporosis	0.000131	0.000292	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—SPP1—osteoporosis	0.00013	0.000291	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—WNT1—osteoporosis	0.000129	0.000287	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—P4HB—osteoporosis	0.000128	0.000286	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PTHLH—osteoporosis	0.000128	0.000285	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—BMP2—osteoporosis	0.000128	0.000285	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—FGA—osteoporosis	0.000127	0.000284	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PTHLH—osteoporosis	0.000127	0.000283	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—BMP2—osteoporosis	0.000127	0.000283	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—IGF1—osteoporosis	0.000126	0.00028	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—ADCY5—osteoporosis	0.000125	0.00028	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—FGA—osteoporosis	0.000125	0.00028	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—FGB—osteoporosis	0.000125	0.000279	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PTHLH—osteoporosis	0.000125	0.000279	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—BMP2—osteoporosis	0.000125	0.000279	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PTH—osteoporosis	0.000125	0.000279	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—FGB—osteoporosis	0.000124	0.000277	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CALCA—osteoporosis	0.000123	0.000276	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—ADCY5—osteoporosis	0.000123	0.000275	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—RAP1A—osteoporosis	0.000123	0.000274	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—FGB—osteoporosis	0.000122	0.000273	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CNR2—osteoporosis	0.000122	0.000271	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000121	0.00027	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PSMA2—osteoporosis	0.000121	0.00027	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PSMA5—osteoporosis	0.000121	0.00027	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—ADCY5—osteoporosis	0.000121	0.000269	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—POMC—osteoporosis	0.00012	0.000269	CbGpPWpGaD
Droxidopa—PAH—Disease—IL6—osteoporosis	0.00012	0.000269	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NFATC1—osteoporosis	0.00012	0.000267	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PSMA5—osteoporosis	0.00012	0.000267	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PSMA2—osteoporosis	0.00012	0.000267	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—P4HB—osteoporosis	0.000119	0.000266	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—DKK1—osteoporosis	0.000119	0.000265	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—BMP2—osteoporosis	0.000118	0.000264	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PTHLH—osteoporosis	0.000118	0.000264	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PSMA5—osteoporosis	0.000118	0.000264	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PSMA2—osteoporosis	0.000118	0.000264	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IRS2—osteoporosis	0.000118	0.000263	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PTHLH—osteoporosis	0.000116	0.00026	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—BMP2—osteoporosis	0.000116	0.00026	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PTH—osteoporosis	0.000116	0.000259	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—FGB—osteoporosis	0.000116	0.000258	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—LEP—osteoporosis	0.000115	0.000258	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—WNT1—osteoporosis	0.000114	0.000255	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	0.000114	0.000254	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—FGB—osteoporosis	0.000114	0.000254	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CNR2—osteoporosis	0.000113	0.000252	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CALCA—osteoporosis	0.000113	0.000251	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	0.000112	0.00025	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—KL—osteoporosis	0.000112	0.00025	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PSMA2—osteoporosis	0.000112	0.000249	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PSMA5—osteoporosis	0.000112	0.000249	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CALCA—osteoporosis	0.000111	0.000249	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—FGA—osteoporosis	0.000111	0.000248	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	0.000111	0.000248	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—DKK1—osteoporosis	0.00011	0.000246	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—ESR1—osteoporosis	0.00011	0.000246	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ENO1—osteoporosis	0.00011	0.000246	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CALCA—osteoporosis	0.00011	0.000246	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PSMA5—osteoporosis	0.00011	0.000246	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PSMA2—osteoporosis	0.00011	0.000246	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—POMC—osteoporosis	0.00011	0.000245	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	0.00011	0.000245	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—POMC—osteoporosis	0.000109	0.000244	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—POMC—osteoporosis	0.000109	0.000243	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PSMA2—osteoporosis	0.000109	0.000242	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PSMA5—osteoporosis	0.000109	0.000242	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—CYP19A1—osteoporosis	0.000108	0.000242	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—POMC—osteoporosis	0.000107	0.00024	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL6R—osteoporosis	0.000107	0.000238	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—WNT1—osteoporosis	0.000106	0.000237	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CALCA—osteoporosis	0.000104	0.000232	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	0.000103	0.000231	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—BMP2—osteoporosis	0.000103	0.000231	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—FGA—osteoporosis	0.000103	0.000231	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IRS1—osteoporosis	0.000103	0.00023	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CALCA—osteoporosis	0.000102	0.000229	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—KL—osteoporosis	0.000102	0.000228	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	0.000102	0.000227	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—POMC—osteoporosis	0.000102	0.000227	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—KL—osteoporosis	0.000101	0.000226	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—FGB—osteoporosis	0.000101	0.000226	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—POMC—osteoporosis	0.0001	0.000223	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—KL—osteoporosis	9.99e-05	0.000223	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—POMC—osteoporosis	9.96e-05	0.000222	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TGFB1—osteoporosis	9.92e-05	0.000221	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—POMC—osteoporosis	9.92e-05	0.000221	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—POMC—osteoporosis	9.87e-05	0.00022	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	9.77e-05	0.000218	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	9.77e-05	0.000218	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—POMC—osteoporosis	9.75e-05	0.000218	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL6R—osteoporosis	9.72e-05	0.000217	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL6R—osteoporosis	9.67e-05	0.000216	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL6R—osteoporosis	9.63e-05	0.000215	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	9.61e-05	0.000214	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—BMP2—osteoporosis	9.61e-05	0.000214	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IGF1—osteoporosis	9.54e-05	0.000213	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL6R—osteoporosis	9.51e-05	0.000212	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—KL—osteoporosis	9.46e-05	0.000211	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—FGB—osteoporosis	9.4e-05	0.00021	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—KL—osteoporosis	9.31e-05	0.000208	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TGFB1—osteoporosis	9.27e-05	0.000207	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—POMC—osteoporosis	9.22e-05	0.000206	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CALCA—osteoporosis	9.1e-05	0.000203	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—POMC—osteoporosis	9.08e-05	0.000203	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	9.08e-05	0.000203	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	9.08e-05	0.000203	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL6R—osteoporosis	9e-05	0.000201	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	8.88e-05	0.000198	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—ADCY5—osteoporosis	8.86e-05	0.000198	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	8.85e-05	0.000198	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—GPX1—osteoporosis	8.83e-05	0.000197	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—CYP19A1—osteoporosis	8.81e-05	0.000197	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—ADCY5—osteoporosis	8.78e-05	0.000196	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SPP1—osteoporosis	8.5e-05	0.00019	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CALCA—osteoporosis	8.46e-05	0.000189	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—KL—osteoporosis	8.27e-05	0.000185	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	8.25e-05	0.000184	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—MTHFR—osteoporosis	8.15e-05	0.000182	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—POMC—osteoporosis	8.06e-05	0.00018	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—ADCY5—osteoporosis	8e-05	0.000179	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	7.93e-05	0.000177	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	7.87e-05	0.000176	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—ADCY5—osteoporosis	7.83e-05	0.000175	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SPP1—osteoporosis	7.74e-05	0.000173	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IRS2—osteoporosis	7.69e-05	0.000172	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—KL—osteoporosis	7.68e-05	0.000171	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SPP1—osteoporosis	7.67e-05	0.000171	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SPP1—osteoporosis	7.57e-05	0.000169	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TGFB1—osteoporosis	7.53e-05	0.000168	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—LEP—osteoporosis	7.52e-05	0.000168	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—POMC—osteoporosis	7.49e-05	0.000167	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	7.41e-05	0.000165	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	7.31e-05	0.000163	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—IL6—osteoporosis	7.3e-05	0.000163	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	7.29e-05	0.000163	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ADCY5—osteoporosis	7.2e-05	0.000161	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—ESR1—osteoporosis	7.18e-05	0.00016	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GPX1—osteoporosis	7.17e-05	0.00016	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SPP1—osteoporosis	7.17e-05	0.00016	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SPP1—osteoporosis	7.05e-05	0.000157	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IRS2—osteoporosis	7e-05	0.000156	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IRS2—osteoporosis	6.94e-05	0.000155	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—LEP—osteoporosis	6.85e-05	0.000153	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IRS2—osteoporosis	6.85e-05	0.000153	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—LEP—osteoporosis	6.79e-05	0.000152	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IRS1—osteoporosis	6.71e-05	0.00015	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—LEP—osteoporosis	6.7e-05	0.00015	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—MTHFR—osteoporosis	6.62e-05	0.000148	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—ESR1—osteoporosis	6.54e-05	0.000146	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—POMC—osteoporosis	6.52e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—ESR1—osteoporosis	6.48e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IRS2—osteoporosis	6.48e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	6.48e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—POMC—osteoporosis	6.46e-05	0.000144	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—ESR1—osteoporosis	6.4e-05	0.000143	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IRS2—osteoporosis	6.38e-05	0.000142	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—LEP—osteoporosis	6.34e-05	0.000142	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6R—osteoporosis	6.3e-05	0.000141	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SPP1—osteoporosis	6.26e-05	0.00014	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—LEP—osteoporosis	6.24e-05	0.000139	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IGF1—osteoporosis	6.21e-05	0.000139	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IRS1—osteoporosis	6.11e-05	0.000136	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IRS1—osteoporosis	6.06e-05	0.000135	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ESR1—osteoporosis	6.06e-05	0.000135	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	6.02e-05	0.000134	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IRS1—osteoporosis	5.98e-05	0.000133	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ESR1—osteoporosis	5.96e-05	0.000133	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—POMC—osteoporosis	5.89e-05	0.000131	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—POMC—osteoporosis	5.83e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SPP1—osteoporosis	5.82e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—POMC—osteoporosis	5.76e-05	0.000129	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6R—osteoporosis	5.74e-05	0.000128	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MYC—osteoporosis	5.73e-05	0.000128	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TGFB1—osteoporosis	5.72e-05	0.000128	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6R—osteoporosis	5.69e-05	0.000127	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IRS2—osteoporosis	5.67e-05	0.000126	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IGF1—osteoporosis	5.66e-05	0.000126	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IRS1—osteoporosis	5.66e-05	0.000126	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6R—osteoporosis	5.62e-05	0.000125	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IGF1—osteoporosis	5.61e-05	0.000125	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IRS1—osteoporosis	5.57e-05	0.000124	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—LEP—osteoporosis	5.54e-05	0.000124	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IGF1—osteoporosis	5.54e-05	0.000124	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—POMC—osteoporosis	5.45e-05	0.000122	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—POMC—osteoporosis	5.36e-05	0.00012	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6R—osteoporosis	5.31e-05	0.000119	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ESR1—osteoporosis	5.29e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—POMC—osteoporosis	5.29e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IRS2—osteoporosis	5.26e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IGF1—osteoporosis	5.24e-05	0.000117	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6R—osteoporosis	5.23e-05	0.000117	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IGF1—osteoporosis	5.16e-05	0.000115	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—LEP—osteoporosis	5.15e-05	0.000115	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IRS1—osteoporosis	4.95e-05	0.00011	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ESR1—osteoporosis	4.92e-05	0.00011	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—POMC—osteoporosis	4.76e-05	0.000106	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL6—osteoporosis	4.75e-05	0.000106	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6R—osteoporosis	4.65e-05	0.000104	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IRS1—osteoporosis	4.6e-05	0.000103	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IGF1—osteoporosis	4.58e-05	0.000102	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—POMC—osteoporosis	4.43e-05	9.88e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL6—osteoporosis	4.33e-05	9.67e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6R—osteoporosis	4.32e-05	9.64e-05	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL6—osteoporosis	4.31e-05	9.62e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL6—osteoporosis	4.29e-05	9.58e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IGF1—osteoporosis	4.26e-05	9.5e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL6—osteoporosis	4.24e-05	9.46e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL6—osteoporosis	4.01e-05	8.95e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL6—osteoporosis	3.94e-05	8.81e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MYC—osteoporosis	3.73e-05	8.34e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	3.73e-05	8.32e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL6—osteoporosis	3.5e-05	7.82e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MYC—osteoporosis	3.4e-05	7.6e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TGFB1—osteoporosis	3.39e-05	7.58e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MYC—osteoporosis	3.37e-05	7.53e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	3.36e-05	7.51e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MYC—osteoporosis	3.33e-05	7.43e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TGFB1—osteoporosis	3.32e-05	7.41e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL6—osteoporosis	3.26e-05	7.27e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MYC—osteoporosis	3.15e-05	7.03e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	3.14e-05	7.01e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MYC—osteoporosis	3.1e-05	6.92e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	3.09e-05	6.9e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6—osteoporosis	2.81e-05	6.27e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MYC—osteoporosis	2.75e-05	6.15e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	2.75e-05	6.13e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MYC—osteoporosis	2.56e-05	5.71e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6—osteoporosis	2.56e-05	5.71e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	2.55e-05	5.7e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6—osteoporosis	2.53e-05	5.66e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6—osteoporosis	2.5e-05	5.59e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6—osteoporosis	2.37e-05	5.29e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6—osteoporosis	2.33e-05	5.2e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6—osteoporosis	2.07e-05	4.62e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6—osteoporosis	1.92e-05	4.29e-05	CbGpPWpGaD
